|
|
Blood, 1 January 2005, Vol. 105, No. 1, pp. 122-130.
Prepublished online as a Blood First Edition Paper on August 12, 2004; DOI 10.1182/blood-2004-06-2176.
Previous Article | Next Article 
Submitted June 9, 2004
Accepted July 22, 2004
The gamma-carboxyglutamic acid (Gla) domain of anticoagulant protein S is involved in activated protein C-cofactor activity, independently of phospholipid binding
Francois Saller, Bruno O Villoutreix, Aymeric Amelot, Tahar Kaabache, Bernard F Le Bonniec, Martine Aiach, Sophie Gandrille, and Delphine Borgel*
Faculte des Sciences Pharmaceutiques et Biologiques, IFR 71 'Sciences du Medicament', INSERM U428, Universite Paris V, Paris, France
* Corresponding author; email: borgel{at}pharmacie.univ-paris5.fr.
We expressed two chimeras between human protein S (PS) and human prothrombin (FII), in which the prothrombin Gla domain replaced the PS Gla domain in native PS (GlaFII-PS) or in PS deleted of the thrombin-sensitive region (TSR) (GlaFII- TSR-PS). Both PS/FII chimeras had no APC-cofactor activity in plasma clotting assays or purified systems, but bound efficiently to phospholipids. This pointed to a direct involvement of the PS Gla domain in APC-cofactor activity, through molecular interaction with APC. Using computational methods, we identified two opposite faces of solvent-exposed residues on the PS Gla domain (designated Faces 1 and 2) as being potentially involved in this interaction. Their importance was supported by functional characterization of a PS mutant in which the Faces 1 and 2 PS residues were reintroduced into GlaFII-PS, leading to significant APC-cofactor activity, likely via restored interaction with APC. Furthermore, by characterizing PS mutants in which PS Face 1 and PS Face 2 were individually replaced by the corresponding prothrombin faces, we found that Face 1 was necessary for efficient phospholipid binding, while Face 2 residues were not strictly required for phospholipid binding but were involved in the interaction with APC.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Gla glances at proteins
- Tilman M. Hackeng
Blood 2005 105: 1-2.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
S. Harmon, R. J. S. Preston, F. N. Ainle, J. A. Johnson, M. S. Cunningham, O. P. Smith, B. White, and J. S. O'Donnell
Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement
J. Biol. Chem.,
November 7, 2008;
283(45):
30531 - 30539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Saposnik, E. Lesteven, A. Lokajczyk, C. T. Esmon, M. Aiach, and S. Gandrille
Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma
Blood,
April 1, 2008;
111(7):
3442 - 3451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. S. Preston, E. Ajzner, C. Razzari, S. Karageorgi, S. Dua, B. Dahlback, and D. A. Lane
Multifunctional Specificity of the Protein C/Activated Protein C Gla Domain
J. Biol. Chem.,
September 29, 2006;
281(39):
28850 - 28857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Dahlback and B. O. Villoutreix
Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway: Novel Insights Into Structure-Function Relationships and Molecular Recognition
Arterioscler Thromb Vasc Biol,
July 1, 2005;
25(7):
1311 - 1320.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|